1. Home
  2. NSPR vs DARE Comparison

NSPR vs DARE Comparison

Compare NSPR & DARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo InspireMD Inc.

NSPR

InspireMD Inc.

N/A

Current Price

$0.72

Market Cap

33.7M

Sector

Health Care

ML Signal

N/A

Logo Dare Bioscience Inc.

DARE

Dare Bioscience Inc.

N/A

Current Price

$2.04

Market Cap

33.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NSPR
DARE
Founded
2005
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.7M
33.4M
IPO Year
2009
2014

Fundamental Metrics

Financial Performance
Metric
NSPR
DARE
Price
$0.72
$2.04
Analyst Decision
Buy
Strong Buy
Analyst Count
1
2
Target Price
$4.00
$10.00
AVG Volume (30 Days)
116.6K
136.9K
Earning Date
05-04-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,310,000.00
$2,807,885.00
Revenue This Year
$57.98
$2,115.12
Revenue Next Year
$95.41
$122.62
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.63
$1.27
52 Week High
$2.93
$3.78

Technical Indicators

Market Signals
Indicator
NSPR
DARE
Relative Strength Index (RSI) 41.88 48.77
Support Level $0.69 $1.95
Resistance Level $1.04 $2.24
Average True Range (ATR) 0.05 0.11
MACD 0.02 0.01
Stochastic Oscillator 68.23 43.48

Price Performance

Historical Comparison
NSPR
DARE

About NSPR InspireMD Inc.

InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.

About DARE Dare Bioscience Inc.

Dare Bioscience Inc is a biopharmaceutical company committed to advancing products for women's health. The company identifies, develops, and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in clinical development namely, Ovaprene and Sildenafil Cream. It has one operating segment, women's health.

Share on Social Networks: